Skip to main content
Sernova Biotherapeutics Inc (FRA:PSH0)
Germany flag Germany · Delayed Price · Currency is EUR
0.0865
+0.0025 (2.98%)
At close: Dec 4, 2025

Sernova Biotherapeutics Cash Flow Statement

Millions CAD. Fiscal year is Nov - Oct.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
 Jul '25 Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 2019 - 2015
Net Income
-18.51-32.19-39-24.42-6.97-5.32
Upgrade
Depreciation & Amortization
0.450.540.450.440.270.23
Upgrade
Loss (Gain) From Sale of Assets
-0.05-0.02----
Upgrade
Stock-Based Compensation
1.231.753.97.450.220.68
Upgrade
Other Operating Activities
0.02-0.13-0.68-0.84-0.88-0.39
Upgrade
Change in Accounts Receivable
0.30.560.23-0.2-0.090.01
Upgrade
Change in Accounts Payable
1.3510.594.753.310.460.22
Upgrade
Change in Other Net Operating Assets
0.560.010-0.160.140.63
Upgrade
Operating Cash Flow
-14.66-18.9-30.34-14.42-6.84-3.94
Upgrade
Capital Expenditures
---0.1-0.33-0.02-0.01
Upgrade
Sale (Purchase) of Intangibles
------1
Upgrade
Investment in Securities
-11.0834.92-46-2
Upgrade
Other Investing Activities
-0.04-0.04-0.01-0.21-
Upgrade
Investing Cash Flow
011.1234.78-46.34-0.230.99
Upgrade
Long-Term Debt Issued
-----0.97
Upgrade
Long-Term Debt Repaid
--0.17-0.17-0.17-0.03-0.09
Upgrade
Net Debt Issued (Repaid)
4.7-0.17-0.17-0.17-0.030.87
Upgrade
Issuance of Common Stock
5.215.23-36.5527.553.56
Upgrade
Other Financing Activities
-0.190.010.680.283.470.66
Upgrade
Financing Cash Flow
9.725.070.536.66315.1
Upgrade
Net Cash Flow
-4.94-2.714.95-24.123.922.15
Upgrade
Free Cash Flow
-14.66-18.9-30.44-14.75-6.86-3.94
Upgrade
Free Cash Flow Per Share
-0.04-0.06-0.10-0.05-0.03-0.02
Upgrade
Levered Free Cash Flow
-7.87-6.65-16.13-5.56-3.19-2.34
Upgrade
Unlevered Free Cash Flow
-7.11-6.29-16.11-5.53-3.18-2.34
Upgrade
Change in Working Capital
2.2111.164.992.950.520.86
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.